CVS Beats Wall Street As It Revamps Corporate Structure

CVS Q3 Tops Estimates as Retail Revenues Gain

Third quarter earnings and income at CVS Health beat Wall Street estimates despite unadjusted losses from an opioid litigation settlement. Company net loss was $3.42 billion, or $2.60 per diluted share, versus net income of $1.6 billion, or $1.20 per diluted share, in...
CVS Beats Wall Street As It Revamps Corporate Structure

CVS Beats Expections in Q2

As the company continues on its reorganization as a community well resource, CVS Health beat Wall Street estimates on earnings and revenues while posting a strong comparable sales gain in the retail business. Company net income was $2.95 billion, or $2.23 per diluted...